Showing results (181-190 of 553) with videos related to
Sort By:
Pageof 56
Drugs in Context|September 30, 2020
TAS-102 in metastatic colorectal cancer (mCRC): efficacy, tolerability, and quality of life in heavily pretreated elderly patients: a real-life studyGiuseppe Cicero, Raffaele Addeo, Rossella De Luca, et al.Drugs in Context|November 26, 2020
Emerging systemic JAK inhibitors in the treatment of atopic dermatitis: a review of abrocitinib, baricitinib, and upadacitinibNovin Nezamololama, Keira Fieldhouse, Kristy Metzger, et al.Drugs in Context|January 7, 2021
Sustained virological response in patients with HCV treated with daclatasvir plus sofosbuvir, with or without ribavirin: a large, field-practice studyRodolfo Sacco, Vincenzo Messina, Umberto Vespasiani Gentilucci, et al.Drugs in Context|January 28, 2021
Efficacy and safety of rituximab in the treatment of connective tissue disease-related interstitial lung diseaseCaterina Vacchi, Andreina Manfredi, Giulia Cassone, et al.Drugs in Context|January 28, 2021
Efficacy of cyclophosphamide in treating connective tissue disease-related interstitial lung diseasesValeria Nucera, Elisabetta Gerratana, Manuela Giallanza, et al.Drugs in Context|January 28, 2021
Antifibrotic drugs in connective tissue disease-related interstitial lung disease (CTD-ILD): from mechanistic insights to therapeutic applicationsGian Luca Erre, Marco Sebastiani, Andreina Manfredi, et al.Drugs in Context|January 17, 2022
Portuguese recommendations for the treatment of atopic dermatitis with biologic therapy and JAK inhibitors in adult patientsTiago Torres, Margarida Gonçalo, Maria João Paiva Lopes, et al.Drugs in Context|December 31, 2021
Academic detailing interventions for opioid-related outcomes: a scoping reviewVictoria Kulbokas, Kent A Hanson, Mary H Smart, et al.Drugs in Context|October 28, 2022
Non-small-cell lung cancer: how to manage ALK-, ROS1- and NTRK-rearranged diseaseDaniele Marinelli, Marco Siringo, Giulio Metro, et al.Drugs in Context|April 27, 2019
Brodalumab in psoriasis: evidence to date and clinical potentialAmy C Foulkes, Richard B WarrenPageof 56